I/Ontak isour leadassetThere are noFDAapproveddrugs to treathemorrhoidsAn actualiMSCupdateI'm ashareholdermyselfI/ONTAKwas thebest deal Iever madeWe intendto submita BLA in2H 2022Mino-Lokpotentialmarket>$1BOur Halo-Lido trial willhave finalpatient byend of 2022Hemorrhoidsis a $2BmarketOnly biotechwith 2 Myron'son theleadershipteamInsidersinvested$26.5mI/ONTAK'spotentialmarket is>$300mMyron Holubiakand I founded aprivatecompany in2013We expect tofinish theMino-Loktrial this yearMino-Lokis our leadassetI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.The name Citiuscomes from theOlympic motto"Citius,AltiusForius"Not manycompaniesthis size with2 late stageassetsI won't diluteshareholdersWe will openupinternationalsites forMino-Lok trialWe haveenough cashto go wellinto 2023We had aphase 2btrial with100%efficacyWe willhaveexclusivityMino-WrapI/Ontak isour leadassetThere are noFDAapproveddrugs to treathemorrhoidsAn actualiMSCupdateI'm ashareholdermyselfI/ONTAKwas thebest deal Iever madeWe intendto submita BLA in2H 2022Mino-Lokpotentialmarket>$1BOur Halo-Lido trial willhave finalpatient byend of 2022Hemorrhoidsis a $2BmarketOnly biotechwith 2 Myron'son theleadershipteamInsidersinvested$26.5mI/ONTAK'spotentialmarket is>$300mMyron Holubiakand I founded aprivatecompany in2013We expect tofinish theMino-Loktrial this yearMino-Lokis our leadassetI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.The name Citiuscomes from theOlympic motto"Citius,AltiusForius"Not manycompaniesthis size with2 late stageassetsI won't diluteshareholdersWe will openupinternationalsites forMino-Lok trialWe haveenough cashto go wellinto 2023We had aphase 2btrial with100%efficacyWe willhaveexclusivityMino-Wrap

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
G
2
I
3
B
4
G
5
I
6
O
7
G
8
B
9
O
10
G
11
B
12
N
13
O
14
B
15
I
16
N
17
O
18
I
19
G
20
B
21
O
22
N
23
I
24
N
  1. G-I/Ontak is our lead asset
  2. I-There are no FDA approved drugs to treat hemorrhoids
  3. B-An actual iMSC update
  4. G-I'm a shareholder myself
  5. I-I/ONTAK was the best deal I ever made
  6. O-We intend to submit a BLA in 2H 2022
  7. G-Mino-Lok potential market >$1B
  8. B-Our Halo-Lido trial will have final patient by end of 2022
  9. O-Hemorrhoids is a $2B market
  10. G-Only biotech with 2 Myron's on the leadership team
  11. B-Insiders invested $26.5m
  12. N-I/ONTAK's potential market is >$300m
  13. O-Myron Holubiak and I founded a private company in 2013
  14. B-We expect to finish the Mino-Lok trial this year
  15. I-Mino-Lok is our lead asset
  16. N-I/ONTAK was previously approved but taken off the market to improve manufacturing.
  17. O-The name Citius comes from the Olympic motto "Citius,Altius Forius"
  18. I-Not many companies this size with 2 late stage assets
  19. G-I won't dilute shareholders
  20. B-We will open up international sites for Mino-Lok trial
  21. O-We have enough cash to go well into 2023
  22. N-We had a phase 2b trial with 100% efficacy
  23. I-We will have exclusivity
  24. N-Mino-Wrap